Patents by Inventor Eric Claassen

Eric Claassen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND MEANS FOR MODIFYING HEMODYNAMICS IN INFECTIONS
    Publication number: 20230241155
    Abstract: Provided is a method of treatment comprising administering an AQGV peptide, or a functional analogue thereof, to a human subject, the human subject suffering from an infection, particularly a respiratory infection, more specifically, a viral infection, more in particular, a Corona virus infection, wherein the treatment of administering an AQGV peptide comprises maintaining or improving hemodynamic stability in the human subject.
    Type: Application
    Filed: April 6, 2021
    Publication date: August 3, 2023
    Inventors: Gert Wensvoort, Eric Claassen, Johan Renes
  • Treatment of T cell mediated autoimmune disorders
    Publication number: 20020009450
    Abstract: Method for the treatment of multiple sclerosis and other T cell mediated autoimmune disorders is described. The method involves administering to a subject a therapeutically effective amount of an antagonist of a receptor on a surface of a T cell which mediates contact dependent helper effector functions, for example, an anti-gp39 antibody.
    Type: Application
    Filed: May 8, 2001
    Publication date: January 24, 2002
    Applicant: Trustees of Darmouth College
    Inventors: Randolph J. Noelle, Eric Claassen
  • Method to treat multiple sclerosis with GP39-specific antibodies
    Patent number: 6328964
    Abstract: Method for the treatment of multiple sclerosis and other T cell mediated autoimmune disorders is described. The method involves administering to a subject a therapeutically effective amount of an antagonist of a receptor on a surface of a T cell which mediates contact dependent helper effector functions, for example, an anti-gp39 antibody.
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: December 11, 2001
    Assignees: Trustees of Dartmouth College, Nederlandse Organisatie Voor Teogepastnatuurwetenschappelijk Onderzoek TNO
    Inventors: Randolph J. Noelle, Eric Claassen
  • Treatment of T cell mediated autoimmune disorders
    Patent number: 5833987
    Abstract: Method for the treatment of multiple sclerosis and other T cell mediated autoimmune disorders is described. The method involves administering to a subject a therapeutically effective amount of an antagonist of a receptor on a surface of a T cell which mediates contact dependent helper effector functions, for example, an anti-gp39 antibody.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 10, 1998
    Assignees: Trustees of Dartmouth College, Nederlanse Organisatie Voor Teogepastnatuurwetenschappelijk Onderzoek TNO
    Inventors: Randolph J. Noelle, Eric Claassen